[HTML][HTML] Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration
Enteral administration is the most convenient route despite the gastrointestinal physiological
barriers. Nanostructured lipid carriers (NLCs) have emerged as a promising strategy for …
barriers. Nanostructured lipid carriers (NLCs) have emerged as a promising strategy for …
[HTML][HTML] Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment
P Graván, A Aguilera-Garrido, JA Marchal… - Advances in Colloid and …, 2023 - Elsevier
Nanotechnological drug delivery platforms represent a new paradigm for cancer
therapeutics as they improve the pharmacokinetic profile and distribution of …
therapeutics as they improve the pharmacokinetic profile and distribution of …
Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications …
The lipid-based colloidal carriers, such as nanostructured lipid carriers (NLCs), solid lipid
nanoparticles (SLNs), nanocapsules, liposomes, and microemulsion, are the latest and …
nanoparticles (SLNs), nanocapsules, liposomes, and microemulsion, are the latest and …
Intranasal delivery: an attractive route for the administration of nucleic acid based therapeutics for CNS disorders
The etiologies of several cardiovascular, inflammatory, neurological, hereditary disorders,
cancer, and infectious diseases have implicated changes in the genetic set up or genetic …
cancer, and infectious diseases have implicated changes in the genetic set up or genetic …
Engineering of clarithromycin loaded stimulus responsive dissolving microneedle patches for the treatment of biofilms
This study aimed to fabricate clarithromycin laden Eudragit S-100-based microfibers (MF),
microfibers coated film (MB), clarithromycin loaded polyvinyl pyrollidone, hyaluronic acid …
microfibers coated film (MB), clarithromycin loaded polyvinyl pyrollidone, hyaluronic acid …
Fabrication of oral sustained release capecitabine loaded nanostructured lipid carriers with improved bioavailability and prolonged anticancer effects
This study aims to develop a sustained release dosage form of capecitabine (CAP) using
nanostructured lipid carriers (NLCs) to improve its pharmacokinetic and antitumor profile …
nanostructured lipid carriers (NLCs) to improve its pharmacokinetic and antitumor profile …
CMC/Starch/SiO2/GQDs nanoemulsion for targeted delivery of 5-fluorouracil
Z Jamalpoor, H Ahmadi, M Abdous, A Rahdar - Journal of Molecular …, 2024 - Elsevier
Nanoemulsions, defined as colloidal particulate systems with sizes within the submicron
range, function as effective carriers for drug molecules. Carboxymethyl cellulose (CMC), a …
range, function as effective carriers for drug molecules. Carboxymethyl cellulose (CMC), a …
Ingestible Artificial Urinary Biomarker Probes for Urine Test of Gastrointestinal Cancer
Although colorectal cancer diagnosed at an early stage shows high curability, methods
simultaneously possessing point‐of‐care testing ability and high sensitivity are limited. Here …
simultaneously possessing point‐of‐care testing ability and high sensitivity are limited. Here …
[HTML][HTML] A pH-sensitive silica nanoparticles for colon-specific delivery and controlled release of catechin: Optimization of loading efficiency and in vitro release kinetics
AM Kassem, M Almukainzi, TM Faris, AH Ibrahim… - European Journal of …, 2024 - Elsevier
Catechin is a naturally occurring flavonoid of the flavan-3-ol subclass with numerous
biological functions; however, these benefits are diminished due to several factors, including …
biological functions; however, these benefits are diminished due to several factors, including …
Discerning computational, in vitro and in vivo investigations of self-assembling empagliflozin polymeric micelles in type-2 diabetes
P Wagh, S Savaliya, B Joshi, B Vyas… - Drug Delivery and …, 2024 - Springer
Background Empagliflozin (EMPA) is an SGLT2 inhibitor, a new class of anti-diabetic
medication, indicated for treating type-2 diabetes. Its low permeability, poor solubility and …
medication, indicated for treating type-2 diabetes. Its low permeability, poor solubility and …